Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review

from Research To Practice | Oncology Videos · host Dr. Neil Love

Featuring an interview with Dr Terence Friedlander, including the following topics: Final analysis of the Phase III, open-label, randomized POTOMAC trial (0:00) KEYNOTE-905 trial: Perioperative enfortumab vedotin with pembrolizumab for muscle-invasive bladder cancer (MIBC) (5:25) The neoadjuvant gemcitabine intravesical system TAR-200 for patients with MIBC: Primary analysis of the SunRISe-4 trial (14:07) Circulating tumor DNA-guided therapies for MIBC (18:41) CME information and select publications

Episode metadata supplied by the publisher feed · Published Feb 5, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review

0:00 31:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Research To Practice | Oncology Videos?

This episode is 31 minutes long.

When was this Research To Practice | Oncology Videos episode published?

This episode was published on February 5, 2026.

Can I download this Research To Practice | Oncology Videos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!